Keratoacanthomas associated with imatinib mesylate.
Yevgeniy
Y
Balagula
Klaus J
KJ
Busam
Richard D
RD
Carvajal
Jedd D
JD
Wolchok
Patricia L
PL
Myskowski
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D007636:Keratoacanthoma / Q000139:chemically induced* / Q000601:surgery; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate